Navigate European market access with clarity
Strategic market access and reimbursement advice for medical technology companies
Innovation alone does not create impact
Fragmented European markets
Different Healthcare Systems and National Funding Pathways
Increasing evidence expectations
Evolving Health Technology Assessment and Reimbursement Requirements
Bringing a medical technology to market requires more than regulatory approval.
It requires a clear understanding of healthcare systems, reimbursement pathways, evidence expectations and country specific adoption requirements.
VaLe Access helps MedTech companies understand these complexities, assess their options and define practical next steps.
The Vale Access Framework guides companies from Value to Impact
01
Value
Demonstrate the clinical and economic value
02
Access
Translate value into funding, reimbursement and adoption
03
Impact
Bring innovation to more users and patients
Experience that connects strategy with practice
20+
years in global MedTech companies
Broad expertise
Full product Spectrum
Stakeholder Engagement
Have a Market Access Challenge?
Let's explore how VaLe Access can support your next step